The evacuations were suspended after an individual who was contracted to provide services to the WHO in Gaza was killed during a security incident, Tedros said.
The World Health Organization (WHO) suspended medical evacuations of patients from Gaza to Egypt via the Rafah border crossing until further notice, WHO Director-General Dr. Tedros Adhanom Ghebreyesus announced Monday night.
The evacuations were suspended after an individual who was contracted to provide services to the WHO in Gaza was killed during a security incident, Tedros said.
Two WHO staff members were present at the incident but were not injured.
No other details of the incident were shared. However, Tedros wrote that it “is under investigation by the relevant authorities.”
The Rafah crossing
Medical evacuations via the Rafah crossing were last suspended between 23 and 25 March due to unsafe conditions. Rafah is currently the only point of access to outside medical care for those within Gaza.
According to the WHO, on March 27, thousands of patients still await medical evacuation from Gaza.
LATEST POSTS
- 1
NASA releases new ‘Earthset’ and eclipse images taken during historic flyby of the moon - 2Top 5 Top of the line Books of the Year
- 32 bright planets light up April evenings — here's where and when to look
- 4NASA Perseverance rover sees megaripples on Mars | Space photo of the day for Jan. 7, 2026.
- 5These 2 moon rovers used cameras and lasers to hunt for simulated water ice — and one looks like WALL-E
- Most loved Seared Chicken: Which Chain Rules?
- Air travelers face higher ticket prices as Iran war drives up oil prices
- The Electric Bicycle Americans Can Confide in 2024
- Heat Wave Fuels Massive Wildfire In Australia
- China's 'Venice Of The East' Is A Historic Canal City Near Shanghai With Arched Bridges And Lantern-Lit Waterways
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- Illegal entries into Germany halve over two years, border police say
- Two Passover initiatives target isolation and safety for Israel’s elderly
- Merck sees over $5 billion opportunity in Cidara's experimental flu drug
